Schering-Plough Animal Health Corporation, Union, N.J., forms an agreement to acquire from Pfizer Inc., New York, the U.S. distribution and marketing rights to Pfizer Animal Health's intramammary antibiotic infusion products Dariclox[R], Amoxi-Mast[R] and Orbenin-DC[R]. (At Closing News).Schering-Plough Animal Health Corporation, Union, N.J., forms an agreement to acquire from Pfizer Inc., New York, the U.S. distribution and marketing rights to Pfizer Animal Health's intramammary antibiotic infusion products Dariclox[R], Amoxi-Mast[R] and Orbenin-DC[R]. Dariclox (sodium cloxacillin cloxacillin /clox·a·cil·lin/ (klok?sah-sil´in) a semisynthetic penicillin; used as the sodium salt to treat staphylococcal infections due to penicillinase-positive organisms. ) and Amoxi-Mast (amoxicillin trihydrate) are approved by the U.S. Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) for the treatment of mastitis mastitis (măstī`tĭs), inflammation of the breast. Mastitis most commonly occurs in nursing mothers between the first and third weeks after childbirth, usually of the first child. (inflammation) in lactating lac·tate 1 intr.v. lac·tat·ed, lac·tat·ing, lac·tates To secrete or produce milk. [Latin lact dairy cattle. Orbenin-DC (benzathine cloxacillin) is approved by the FDA for the treatment and prevention of mastiffs in non-lactating dairy cattle. "The acquisition of these products expands Schering-Plough Animal Health's antibiotics product line and strengthens our presence in the livestock market," said Raul E. Kohan, president, Schering-Plough Animal Health. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion